Aidan J. Hampson - Concepedia

Author

Aidan J. Hampson

National Institute on Drug Abuse

Also Known As

A Hampson, A. J. HAMPSON, A. J. Hampson, A.J. Hampson, Aidan Hampson, Aidan J. Hampson, Hampson, Aidan J.

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

National Institute on Drug Abuse National Institutes of Health University of Florida National Institute of Neurological Disorders and Stroke University of California, San Francisco

About

Aidan J. Hampson is an author at National Institute on Drug Abuse specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	830
2	Social Sciences	6	6	757
3	Biochemistry	4	4	226
4	Natural Sciences	2	2	72
5	Anesthesia	1	1	42

Aidan J. Hampson

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Cannabidiol and (−)Δ <sup>9</sup> -tetrahydrocannabinol are neuroprotective antioxidants Aidan J. Hampson, M. Grimaldi, J Axelrod, Proceedings of the National Academy of Sciences	1998	841
Dual Effects of Anandamide on NMDA Receptor‐Mediated Responses and Neurotransmission Aidan J. Hampson, Lester M. Bornheim, Massimo Scanziani, Journal of Neurochemistry Synaptic TransmissionNeurotransmitterCannabinoid PharmacologySocial SciencesMolecular Pharmacology	1998	205
Neuroprotective Antioxidants from Marijuana<sup>a</sup> Aidan J. Hampson, M. Grimaldi, M. LOLIC, Annals of the New York Academy of Sciences Glutamate ToxicityNeuroprotective AntioxidantsCannabis UseMedicineNeuropharmacology	2000	203
Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity Carol Hamelink, Aidan J. Hampson, David A. Wink, Journal of Pharmacology and Experimental Therapeutics	2005	187
Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor Aidan J. Hampson, Winfield Hill, Magda Zan-Phillips, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Cannabis UsePsychoactive DrugBiochemistryFunctional SelectivityMedicine	1995	130
Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP) Brian D. Klein, Catherine Jacobson, Cameron S. Metcalf, Neurochemical Research NeurophysiologyMedicineAnimal Seizure ModelsNeuropharmacologyNeurology	2017	122
Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl Laura C. Chambers, Benjamin D. Hallowell, Andrew R. Zullo, JAMA Network Open	2023	102
Activity of <i>Mitragyna speciosa</i> (“Kratom”) Alkaloids at Serotonin Receptors Francisco León, Samuel Obeng, Marco Mottinelli, Journal of Medicinal Chemistry	2021	71
Exploring the Chemistry of Alkaloids from Malaysian <i>Mitragyna speciosa</i> (Kratom) and the Role of Oxindoles on Human Opioid Receptors Nelson Jeng‐Yeou Chear, Francisco León, Abhisheak Sharma, Journal of Natural Products	2021	70
Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy Shyam H. Kamble, Francisco León, Tamara I. King, ACS Pharmacology & Translational Science	2020	64

Page 1